BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16006883)

  • 1. Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate.
    Uetsuki H; Tsunemori H; Taoka R; Haba R; Ishikawa M; Kakehi Y
    J Urol; 2005 Aug; 174(2):514-8. PubMed ID: 16006883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum level of early prostate cancer antigen is associated with subsequent cancer risk in men with high-grade prostatic intraepithelial neoplasia.
    Zhao Z; Zeng G
    Endocr Relat Cancer; 2010 Jun; 17(2):505-12. PubMed ID: 20308359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.
    Altinok G; Powell IJ; Che M; Hormont K; Sarkar FH; Sakr WA; Grignon D; Liao DJ
    Prostate Cancer Prostatic Dis; 2006; 9(1):77-82. PubMed ID: 16331298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between histological type and immunohistochemical profile of prostate cancer and gleason scale gradation.
    Iemelynova AA; Grygorenko VM; Cheremuha SV; Romanenko AM
    Exp Oncol; 2009 Dec; 31(4):246-9. PubMed ID: 20010526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy.
    Morote J; Fernández S; Alaña L; Iglesias C; Planas J; Reventós J; Ramón Y Cajal S; Paciucci R; de Torres IM
    Clin Cancer Res; 2008 May; 14(9):2617-22. PubMed ID: 18451224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
    Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH
    Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
    Hansel DE; DeMarzo AM; Platz EA; Jadallah S; Hicks J; Epstein JI; Partin AW; Netto GJ
    J Urol; 2007 May; 177(5):1736-40. PubMed ID: 17437801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue.
    Hobisch A; Rogatsch H; Hittmair A; Fuchs D; Bartsch G; Klocker H; Bartsch G; Culig Z
    J Pathol; 2000 Jul; 191(3):239-44. PubMed ID: 10878544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.
    Liao Y; Abel U; Grobholz R; Hermani A; Trojan L; Angel P; Mayer D
    Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.
    Kunju LP; Chinnaiyan AM; Shah RB
    Histopathology; 2005 Dec; 47(6):587-96. PubMed ID: 16324196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
    Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
    Stewart J; Fleshner N; Cole H; Toi A; Sweet J
    J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer antigen-1 as a potential novel marker for prostate cancer.
    Liu BQ; Wu YD; Li PH; Wei JX; Zhang T; Liu RL
    Asian J Androl; 2007 Nov; 9(6):821-6. PubMed ID: 17968469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ezrin in prostatic intraepithelial neoplasia.
    Pang ST; Fang X; Valdman A; Norstedt G; Pousette A; Egevad L; Ekman P
    Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
    Bostwick DG; Qian J; Maihle NJ
    Prostate; 2004 Feb; 58(2):164-8. PubMed ID: 14716741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.